Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: Lowest/Lower Bid
Comprehensive Land Claim Agreement: No
Nature of Requirements:
Pneumococcal Conjugate Vaccine
E60PH-18PCVC/A
Duplin-Vu(ph870), Kim André
Telephone No. - (819) 639-5718
Fax No. - (819) 956-7340
Line 1, Pneumococcal Conjugate Vaccine
Description:
To contract for the supply of the Pneumococcal Conjugate vaccine (PCV) vaccine from April 1, 2018 to March 31, 2019 with an option to extend the term of the Contract by up to three additional one year period under the same conditions.
Maximum Estimated Quantities by vaccines for the firm year:
Pneumococcal Conjugate Vaccine: 342,000 doses
This requirement falls within the Federal/Provincial/Territorial Group Purchasing Program for Drugs and Vaccines. Canada is acting as an agent on behalf of the provincial and territorial jurisdictions.
Designated Users will be obligated to purchase a minimum of 75% of the maximum estimated quantities. Any resulting contract will include the option to add new users at a price not to exceed the Contract price and subject to the same conditions of the Contract.
Basis of Selection:
A bid must comply with the requirements of the bid solicitation and meet all mandatory evaluation criteria to be declared responsive. The responsive bid with the lowest evaluated price will be recommended for award of a contract.
Delivery Date: 07/03/2018
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
